{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T05:47:53Z","timestamp":1782712073384,"version":"3.54.5"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Immunotherapy has emerged as a promising strategy for pancreatic cancer. Radiotherapy not only mediates direct tumor cell killing but also provides a source of tumor antigens for dendritic cells (DCs) uptake and presentation via the induction of immunogenic cell death (ICD). However, the limited antigen presentation efficiency following radiotherapy and the rapid enzymatic degradation of adjuvants within the tumor microenvironment hinder the subsequent efficacy of immunotherapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We developed an\n                      <jats:italic>in situ<\/jats:italic>\n                      hydrogel vaccine, Gel-FOLactis. Combined with 8Gy radiotherapy for treatment. This\n                      <jats:italic>in situ<\/jats:italic>\n                      vaccine employs a thermosensitive P407 hydrogel to encapsulate engineered\n                      <jats:italic>Lactococcus lactis<\/jats:italic>\n                      (FOLactis), enabling sustained intratumoral delivery of the immune-stimulating cytokines Fms-like tyrosine kinase 3 ligand (Flt3L) and co-stimulator OX40 ligand (OX40L).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The sustained release of Flt3L recruits and expands conventional type 1 dendritic cells, enhancing their antigen presentation capability for radiotherapy-released antigens. Concurrently, OX40L promotes the activation of tumor-infiltrating effector T cells. This synergy efficiently initiates a potent antigen-specific immune response, leading to improved tumor eradication.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The combined therapy of RH-FOLactis significantly enhanced the anti-tumor immune response and successfully transformed the immunosuppressive tumor microenvironment in pancreatic cancer from \"cold\" to \"hot\". These findings highlight the potential of RH-FOLactis as a novel and effective treatment strategy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1789212","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T05:39:41Z","timestamp":1782711581000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Radiotherapy-synergized in situ hydrogel vaccine with engineered Lactococcus lactis FOLactis potentiates anti-tumor immunity in pancreatic cancer"],"prefix":"10.3389","volume":"17","author":[{"given":"Jingjing","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Oncology, Nanjing Drum Tower Hospital, Clinical College of Nanjing Drum Tower Hospital, Nanjing University of Chinese Medicine","place":["Nanjing, China"]},{"name":"The Comprehensive Cancer Center of Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaoli","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Oncology, Nanjing Drum Tower Hospital, Clinical College of Nanjing Drum Tower Hospital, Nanjing University of Chinese Medicine","place":["Nanjing, China"]},{"name":"The Comprehensive Cancer Center of Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junmeng","family":"Zhu","sequence":"additional","affiliation":[{"name":"Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyuan","family":"Bai","sequence":"additional","affiliation":[{"name":"Department of Oncology, Nanjing Drum Tower Hospital, Clinical College of Nanjing Drum Tower Hospital, Nanjing University of Chinese Medicine","place":["Nanjing, China"]},{"name":"The Comprehensive Cancer Center of Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haochen","family":"Tang","sequence":"additional","affiliation":[{"name":"The Comprehensive Cancer Center of Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Kong","sequence":"additional","affiliation":[{"name":"The Comprehensive Cancer Center of Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Zou","sequence":"additional","affiliation":[{"name":"Department of Oncology, Nanjing Drum Tower Hospital, Clinical College of Nanjing Drum Tower Hospital, Nanjing University of Chinese Medicine","place":["Nanjing, China"]},{"name":"The Comprehensive Cancer Center of Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghua","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Nanjing Drum Tower Hospital, Clinical College of Nanjing Medical University","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingxin","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Oncology, Nanjing Drum Tower Hospital, Clinical College of Nanjing Drum Tower Hospital, Nanjing University of Chinese Medicine","place":["Nanjing, China"]},{"name":"Department of Laboratory Medicine, Nanjing Drum Tower Hospital, Clinical College of Nanjing Medical University","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Oncology, Nanjing Drum Tower Hospital, Clinical College of Nanjing Drum Tower Hospital, Nanjing University of Chinese Medicine","place":["Nanjing, China"]},{"name":"The Comprehensive Cancer Center of Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baorui","family":"Liu","sequence":"additional","affiliation":[{"name":"The Comprehensive Cancer Center of Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanyan","family":"Meng","sequence":"additional","affiliation":[{"name":"Department of Oncology, Nanjing Drum Tower Hospital, Clinical College of Nanjing Drum Tower Hospital, Nanjing University of Chinese Medicine","place":["Nanjing, China"]},{"name":"Department of Laboratory Medicine, Nanjing Drum Tower Hospital, Clinical College of Nanjing Medical University","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Du","sequence":"additional","affiliation":[{"name":"Department of Oncology, Nanjing Drum Tower Hospital, Clinical College of Nanjing Drum Tower Hospital, Nanjing University of Chinese Medicine","place":["Nanjing, China"]},{"name":"The Comprehensive Cancer Center of Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3322\/caac.21871","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA: A Cancer J For Clin"},{"key":"B2","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.ccell.2020.08.004","article-title":"Challenges and opportunities for pancreatic cancer immunotherapy","volume":"38","author":"Bear","year":"2020","journal-title":"Cancer Cell"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1097\/sla.0000000000003770","article-title":"Optimal adjuvant treatment approach after upfront resection of pancreatic cancer: Revisiting the role of radiation based on pathologic features","volume":"274","author":"Moaven","year":"2021","journal-title":"Ann Surg"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2994","DOI":"10.1002\/1878-0261.12851","article-title":"Targeting immunogenic cell death in cancer","volume":"14","author":"Ahmed","year":"2020","journal-title":"Mol Oncol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41419-023-06211-2","article-title":"Radiotherapy remodels the tumor microenvironment for enhancing immunotherapeutic sensitivity","volume":"14","author":"Liu","year":"2023","journal-title":"Cell Death Dis"},{"key":"B6","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/s41392-023-01462-z","article-title":"Radiation-induced tumor immune microenvironments and potential targets for combination therapy","volume":"8","author":"Guo","year":"2023","journal-title":"Signal Transduction Targeted Ther"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2024-333492","article-title":"Induction of macrophage efferocytosis in pancreatic cancer via PI3K\u03b3 inhibition and radiotherapy promotes tumour control","volume":"74","author":"Russell","year":"2025","journal-title":"Gut"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13040678","article-title":"Enhance the immune checkpoint inhibitors efficacy with radiotherapy induced immunogenic cell death: A comprehensive review and latest developments","volume":"13","author":"Procureur","year":"2021","journal-title":"Cancers"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00042.2019","article-title":"Microenvironmental determinants of pancreatic cancer","volume":"100","author":"Hessmann","year":"2020","journal-title":"Physiol Rev"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.Cd-21-0003","article-title":"Low-dose radiotherapy reverses tumor immune desertification and resistance to immunotherapy","volume":"12","author":"Herrera","year":"2022","journal-title":"Cancer Discov"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-024-00974-9","article-title":"Enhancing in situ cancer vaccines using delivery technologies","volume":"23","author":"Gong","year":"2024","journal-title":"Nat Rev Drug Discov"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2021.09.006","article-title":"Bacteria-based immune therapies for cancer treatment","volume":"86","author":"Howell","year":"2022","journal-title":"Semin Cancer Biol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2021.114085","article-title":"Bacteria and bacterial derivatives as delivery carriers for immunotherapy","volume":"181","author":"Kang","year":"2022","journal-title":"Adv Drug Delivery Rev"},{"key":"B14","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.actbio.2021.02.006","article-title":"Genetically engineered oncolytic bacteria as drug delivery systems for targeted cancer theranostics","volume":"124","author":"Chen","year":"2021","journal-title":"Acta Biomater"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202003572","article-title":"Bacteria-based cancer immunotherapy","volume":"8","author":"Huang","year":"2021","journal-title":"Advanced Sci (Weinheim Baden-Wurttemberg Germany)"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1002\/imt2.70070","article-title":"The microbiome in cancer","volume":"4","author":"Lin","year":"2025","journal-title":"iMeta"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/imt2.156","article-title":"Gut microbiota reshapes cancer immunotherapy efficacy: Mechanisms and therapeutic strategies","volume":"3","author":"Xie","year":"2024","journal-title":"iMeta"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-020-00143-y","article-title":"Flt3 ligand augments immune responses to anti-DEC-205-NY-ESO-1 vaccine through expansion of dendritic cell subsets","volume":"1","author":"Bhardwaj","year":"2020","journal-title":"Nat Cancer"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2020.08.005","article-title":"Targeted delivery of CXCL9 and OX40L by mesenchymal stem cells elicits potent antitumor immunity","volume":"28","author":"Yin","year":"2020","journal-title":"Mol Therapy: J Am Soc Gene Ther"},{"key":"B20","doi-asserted-by":"publisher","first-page":"7466","DOI":"10.1038\/s41467-022-35130-7","article-title":"Engineered Lactococcus lactis secreting Flt3L and OX40 ligand for in situ vaccination-based cancer immunotherapy","volume":"13","author":"Zhu","year":"2022","journal-title":"Nat Commun"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1080\/10717544.2021.1938758","article-title":"Development of thermosensitive poloxamer 407-based microbubble gel with ultrasound mediation for inner ear drug delivery","volume":"28","author":"Liao","year":"2021","journal-title":"Drug Delivery"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.scib.2026.01.022","article-title":"Pharmacotranscriptomics-based discovery and hydrogel-mediated delivery of drug combinations for potentiated cancer immunotherapy","volume":"71","author":"Liu","year":"2026","journal-title":"Sci Bull"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1021\/acsami.5c17119","article-title":"Thermosensitive hydrogel-mediated chemo-photothermal combined immunotherapy for triple-negative breast cancer","volume":"17","author":"Luo","year":"2025","journal-title":"ACS Appl Materials Interfaces"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2025.101882","article-title":"A thermosensitive hydrogel with synergistic stromal targeting and antitumor immunity modulation for pancreatic cancer immunotherapy","volume":"32","author":"Zhao","year":"2025","journal-title":"Mater Today Bio"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1002\/jbm.b.34703","article-title":"Autoclaving of poloxamer 407 hydrogel and its use as a drug delivery vehicle","volume":"109","author":"Beard","year":"2021","journal-title":"J BioMed Mater Res Part B"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2020.10.011","article-title":"Thermosensitive hydrogels for local delivery of 5-fluorouracil as neoadjuvant or adjuvant therapy in colorectal cancer","volume":"157","author":"Al Sabbagh","year":"2020","journal-title":"Eur J Pharmaceutics Biopharmaceutics: Off J Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik Evol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2010.02.011","article-title":"A poloxamer\/chitosan in situ forming gel with prolonged retention time for ocular delivery","volume":"75","author":"Gratieri","year":"2010","journal-title":"Eur J Pharmaceutics Biopharmaceutics: Off J Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik Evol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.120508","article-title":"Development of thermosensitive hydrogel wound dressing containing Acinetobacter baumannii phage against wound infections","volume":"602","author":"Yan","year":"2021","journal-title":"Int J Pharm"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15102421","article-title":"Hydrogel-based therapeutics for pancreatic ductal adenocarcinoma treatment","volume":"15","author":"Liu","year":"2023","journal-title":"Pharmaceutics"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15618","article-title":"DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity","volume":"8","author":"Vanpouille-Box","year":"2017","journal-title":"Nat Commun"},{"key":"B31","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/s12951-022-01422-9","article-title":"Multifunctional thermo-sensitive hydrogel for modulating the microenvironment in osteoarthritis by polarizing macrophages and scavenging RONS","volume":"20","author":"Zhu","year":"2022","journal-title":"J Nanobiotechnol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3390\/ma14164522","article-title":"An overview on thermosensitive oral gel based on poloxamer 407","volume":"14","author":"Chen","year":"2021","journal-title":"Materials (Basel Switzerland)"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3390\/medicines6010007","article-title":"Drug-loaded biocompatible nanocarriers embedded in poloxamer 407 hydrogels as therapeutic formulations","volume":"6","author":"Giuliano","year":"2018","journal-title":"Medicines (Basel Switzerland)"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.890715","article-title":"Distinguishable prognostic signatures and tumor immunogenicity between pancreatic head cancer and pancreatic body\/tail cancer","volume":"12","author":"Ge","year":"2022","journal-title":"Front Oncol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.181.5.3099","article-title":"Radiation-induced CXCL16 release by breast cancer cells attracts effector T cells","volume":"181","author":"Matsumura","year":"2008","journal-title":"J Immunol (Baltimore Md 1950)"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.2147\/ijn.S249174","article-title":"Superior antitumor efficacy of IFN-\u03b12b-incorporated photo-cross-linked hydrogels combined with T cell transfer and low-dose irradiation against gastric cancer","volume":"15","author":"Liu","year":"2020","journal-title":"Int J Nanomed"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2019.110606","article-title":"Thermo-reversible injectable hydrogel composing of pluronic F127 and carboxymethyl hexanoyl chitosan for cell-encapsulation","volume":"185","author":"Yap","year":"2020","journal-title":"Colloids Surfaces B Biointerfaces"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jconrel.2020.03.050","article-title":"Thermosensitive hydrogels as sustained drug delivery system for CTLA-4 checkpoint blocking antibodies","volume":"323","author":"Chung","year":"2020","journal-title":"J Controlled Release: Off J Controlled Release Soc"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12225","article-title":"Establishment and characterization of a novel murine model of pancreatic cancer cachexia","volume":"8","author":"Michaelis","year":"2017","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.034793","article-title":"Orthotopic and heterotopic murine models of pancreatic cancer and their different responses to FOLFIRINOX chemotherapy","volume":"11","author":"Erstad","year":"2018","journal-title":"Dis Models Mech"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1789212\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T05:39:42Z","timestamp":1782711582000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1789212\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,29]]},"references-count":40,"alternative-id":["10.3389\/fimmu.2026.1789212"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1789212","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,29]]},"article-number":"1789212"}}